Cargando…
Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation
BACKGROUND: Little evidence exists regarding the endpoint and optimum approach to catheter ablation for long‐standing persistent atrial fibrillation (LSPAF). We examined the efficacy of pulmonary vein isolation (PVI) plus left atrium posterior wall isolation (PWI) and additional non‐PV trigger ablat...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457393/ https://www.ncbi.nlm.nih.gov/pubmed/31007785 http://dx.doi.org/10.1002/joa3.12168 |
_version_ | 1783409895659274240 |
---|---|
author | Takamiya, Tomomasa Nitta, Junichi Sato, Akira Inamura, Yukihiro Kato, Nobutaka Inaba, Osamu Negi, Ken Yamato, Tsunehiro Matsumura, Yutaka Takahashi, Yoshihide Goya, Masahiko Hirao, Kenzo |
author_facet | Takamiya, Tomomasa Nitta, Junichi Sato, Akira Inamura, Yukihiro Kato, Nobutaka Inaba, Osamu Negi, Ken Yamato, Tsunehiro Matsumura, Yutaka Takahashi, Yoshihide Goya, Masahiko Hirao, Kenzo |
author_sort | Takamiya, Tomomasa |
collection | PubMed |
description | BACKGROUND: Little evidence exists regarding the endpoint and optimum approach to catheter ablation for long‐standing persistent atrial fibrillation (LSPAF). We examined the efficacy of pulmonary vein isolation (PVI) plus left atrium posterior wall isolation (PWI) and additional non‐PV trigger ablation using high‐dose isoproterenol for LSPAF. METHODS: One‐hundred and fifty‐five patients (median AF duration, 36 months) underwent catheter ablation for LSPAF; After PVI plus PWI, they underwent provocation of non‐PV triggers by high‐dose isoproterenol and were divided into 3 groups based on the results: group A, PVI plus PWI alone, without induced non‐PV triggers (single procedure: 105 patients, multiple procedures: 90 patients); group B, mappable non‐PV triggers demonstrated and ablated (single procedure: 41 patients, multiple procedures: 45 patients); group C, if non‐PV triggers were unmappable or could not be induced in repeated procedures, adjunctive complex fractionated atrial electrogram ablation was performed (single procedure: 9 patients, multiple procedures: 20 patients). RESULTS: The Kaplan‐Meier estimate of the 1‐year freedom from atrial tachyarrhythmias without antiarrhythmic drugs was 65% in all patients, (73%, 56%, and 11% in groups A, B, and C, respectively) after a single procedure, which improved to 86% in all patients (93%, 86%, and 53% in groups A, B, and C, respectively) after multiple procedures. CONCLUSION: Even for LSPAF, in approximately 60% of patients, non‐PV triggers were not elicited, and PVI plus PWI alone achieved good outcomes. Although the inducibility of non‐PV triggers was associated with recurrence of atrial tachyarrhythmias, additional non‐PV trigger ablation may improve the outcome after multiple procedures. |
format | Online Article Text |
id | pubmed-6457393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64573932019-04-19 Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation Takamiya, Tomomasa Nitta, Junichi Sato, Akira Inamura, Yukihiro Kato, Nobutaka Inaba, Osamu Negi, Ken Yamato, Tsunehiro Matsumura, Yutaka Takahashi, Yoshihide Goya, Masahiko Hirao, Kenzo J Arrhythm Original Articles BACKGROUND: Little evidence exists regarding the endpoint and optimum approach to catheter ablation for long‐standing persistent atrial fibrillation (LSPAF). We examined the efficacy of pulmonary vein isolation (PVI) plus left atrium posterior wall isolation (PWI) and additional non‐PV trigger ablation using high‐dose isoproterenol for LSPAF. METHODS: One‐hundred and fifty‐five patients (median AF duration, 36 months) underwent catheter ablation for LSPAF; After PVI plus PWI, they underwent provocation of non‐PV triggers by high‐dose isoproterenol and were divided into 3 groups based on the results: group A, PVI plus PWI alone, without induced non‐PV triggers (single procedure: 105 patients, multiple procedures: 90 patients); group B, mappable non‐PV triggers demonstrated and ablated (single procedure: 41 patients, multiple procedures: 45 patients); group C, if non‐PV triggers were unmappable or could not be induced in repeated procedures, adjunctive complex fractionated atrial electrogram ablation was performed (single procedure: 9 patients, multiple procedures: 20 patients). RESULTS: The Kaplan‐Meier estimate of the 1‐year freedom from atrial tachyarrhythmias without antiarrhythmic drugs was 65% in all patients, (73%, 56%, and 11% in groups A, B, and C, respectively) after a single procedure, which improved to 86% in all patients (93%, 86%, and 53% in groups A, B, and C, respectively) after multiple procedures. CONCLUSION: Even for LSPAF, in approximately 60% of patients, non‐PV triggers were not elicited, and PVI plus PWI alone achieved good outcomes. Although the inducibility of non‐PV triggers was associated with recurrence of atrial tachyarrhythmias, additional non‐PV trigger ablation may improve the outcome after multiple procedures. John Wiley and Sons Inc. 2019-02-18 /pmc/articles/PMC6457393/ /pubmed/31007785 http://dx.doi.org/10.1002/joa3.12168 Text en © 2019 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Heart Rhythm Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Takamiya, Tomomasa Nitta, Junichi Sato, Akira Inamura, Yukihiro Kato, Nobutaka Inaba, Osamu Negi, Ken Yamato, Tsunehiro Matsumura, Yutaka Takahashi, Yoshihide Goya, Masahiko Hirao, Kenzo Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title | Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title_full | Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title_fullStr | Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title_full_unstemmed | Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title_short | Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
title_sort | pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high‐dose isoproterenol for long‐standing persistent atrial fibrillation |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457393/ https://www.ncbi.nlm.nih.gov/pubmed/31007785 http://dx.doi.org/10.1002/joa3.12168 |
work_keys_str_mv | AT takamiyatomomasa pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT nittajunichi pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT satoakira pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT inamurayukihiro pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT katonobutaka pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT inabaosamu pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT negiken pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT yamatotsunehiro pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT matsumurayutaka pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT takahashiyoshihide pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT goyamasahiko pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation AT hiraokenzo pulmonaryveinisolationplusleftatrialposteriorwallisolationandadditionalnonpulmonaryveintriggerablationusinghighdoseisoproterenolforlongstandingpersistentatrialfibrillation |